Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ABIRATERONE for Prostate cancer: Side Effects & Safety Data

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

There are 12,209 adverse event reports in the FDA FAERS database where ABIRATERONE was used for Prostate cancer.

Most Reported Side Effects for ABIRATERONE

Side Effect Reports % Deaths Hosp.
Death 5,623 16.3% 5,571 308
Fatigue 1,928 5.6% 77 299
Drug ineffective 1,732 5.0% 106 145
Therapy cessation 1,602 4.6% 17 123
Prostatic specific antigen increased 1,581 4.6% 96 182
Disease progression 1,098 3.2% 122 76
Hospitalisation 1,034 3.0% 99 983
Hot flush 989 2.9% 14 86
Asthenia 891 2.6% 79 333
Off label use 859 2.5% 100 231
Fall 804 2.3% 67 476
Nausea 735 2.1% 62 196
Diarrhoea 731 2.1% 57 204
Hypertension 687 2.0% 43 200
Prostate cancer 661 1.9% 267 163

Other Indications for ABIRATERONE

Product used for unknown indication (12,433) Prostate cancer metastatic (3,535) Hormone-refractory prostate cancer (1,378) Neoplasm malignant (266) Hormone-dependent prostate cancer (236) Metastases to bone (147) Prostate cancer stage iv (94) Bone cancer (67) Neoplasm prostate (50) Metastasis (40)

Other Drugs Used for Prostate cancer

LEUPROLIDE (45,399) ENZALUTAMIDE (25,954) RELUGOLIX (18,752) APALUTAMIDE (3,286) GOSERELIN (2,080) DEGARELIX (2,035) BICALUTAMIDE (1,832) SIPULEUCEL-T (1,720) DENOSUMAB (1,627) DOCETAXEL (1,551)

Related Pages

ABIRATERONE Full Profile All Prostate cancer Drugs ABIRATERONE Demographics ABIRATERONE Timeline